Skip to main content

Omni Partners US LLC

Location
IRVINE, CA
Portfolio Value
Micro $740,000
Diversification
Moderately concentrated
Filing Date
Global Rank
#5,717 / 5,924 ▼ 1006
Top Industry
Biotechnology 35.9%
3Y Alpha vs SPY
-9.6%
Period ended 4 years ago
Filed Nov 15, 2021 · 4y
2 quarters · since Jun 2021

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+37.6%
SPY
+76.3%
Annualised alpha
-9.6%
Max drawdown
−31.3%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

5 positions · as of Sep 30, 2021 · Δ vs Jun 30, 2021
Top Position
29.5%
−59.4 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
2,288
Jun 2021 → Sep 2021 · range 2,288 – 7,964
Moderately concentrated−5,676

Portfolio Trend

2 quarters · across all stocks

Sector Breakdown

As of Sep 30, 2021
Sector % Portfolio Value
Unclassified 29.5% $1,894,973
Healthcare 25.3% $1,621,907
Financial Services 23.0% $1,476,081
Technology 11.5% $740,000
Industrials 10.6% $680,040

Last Quarter's Activity

Export CSV
Sep 30, 2021 vs Jun 30, 2021

Added To

Positions the filer increased
No qualifying positions this quarter.

Trimmed

Positions the filer reduced
1 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
4 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
3 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
1 positions · $740,000 total · Technology only · as of Sep 30, 2021
Ticker Company Shares Value (USD) % of Portfolio History